Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « Hidekata Yasuoka »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hidekara Yasuoka < Hidekata Yasuoka < Hidekazu Furuya  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000965 (2019) Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
001284 (2018) Shinya Tasaki [Japon] ; Katsuya Suzuki [Japon] ; Yoshiaki Kassai [Japon] ; Masaru Takeshita [Japon] ; Atsuko Murota [Japon] ; Yasushi Kondo [Japon] ; Tatsuya Ando [Japon] ; Yusuke Nakayama [Japon] ; Yuumi Okuzono [Japon] ; Maiko Takiguchi [Japon] ; Rina Kurisu [Japon] ; Takahiro Miyazaki [Japon] ; Keiko Yoshimoto [Japon] ; Hidekata Yasuoka [Japon] ; Kunihiro Yamaoka [Japon] ; Rimpei Morita [Japon] ; Akihiko Yoshimura [Japon] ; Hiroyoshi Toyoshiba [Japon] ; Tsutomu Takeuchi [Japon]Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
001776 (2017) Mitsuhiro Akiyama [Japon] ; Hidekata Yasuoka [Japon] ; Tsutomu Takeuchi [Japon]Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.
001C25 (2016) Yuko Kaneko [Japon] ; Tatsuya Atsumi [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
001E56 (2015) Keisuke Izumi [Japon] ; Yuko Kaneko ; Hidekata Yasuoka ; Noriyuki Seta ; Hideto Kameda ; Masataka Kuwana ; Tsutomu TakeuchiTocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Hidekata Yasuoka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Hidekata Yasuoka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Hidekata Yasuoka
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021